{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:24:49Z","timestamp":1791915889886,"version":"4.3.4"},"reference-count":19,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100011944","name":"School of Public Health, University of California Berkeley","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011944","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","jaad.org","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jaad.2024.09.015","type":"journal-article","created":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T23:04:22Z","timestamp":1733007862000},"page":"S37-S41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"S","title":["Antibiotic, hormonal\/metabolic, and retinoid therapies for hidradenitis suppurativa"],"prefix":"10.1016","volume":"91","author":[{"given":"Fonette E.","family":"Fonjungo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandra A.","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8893-9212","authenticated-orcid":false,"given":"Maria A.","family":"Aleshin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jaad.2024.09.015_bib1","doi-asserted-by":"crossref","first-page":"978","DOI":"10.3390\/antibiotics12060978","article-title":"Systemic antibiotic therapy in hidradenitis suppurativa: a review on treatment landscape and current issues","volume":"12","author":"Molinelli","year":"2023","journal-title":"Antibiotics (Basel)"},{"issue":"7","key":"10.1016\/j.jaad.2024.09.015_bib2","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/ijd.15459","article-title":"Treatment of hidradenitis suppurativa with tetracycline, doxycycline, or lymecycline: a prospective study","volume":"60","author":"J\u00f8rgensen","year":"2021","journal-title":"Int J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2024.09.015_bib3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jaad.2019.02.068","article-title":"North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian Hidradenitis Suppurativa Foundations: part II: topical, intralesional, and systemic medical management","volume":"81","author":"Alikhan","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2024.09.015_bib4","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/bjd.19578","article-title":"Effectiveness of clindamycin and rifampicin combination therapy in hidradenitis suppurativa: a 6-month prospective study","volume":"184","author":"Yao","year":"2021","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2024.09.015_bib5","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jaad.2018.11.035","article-title":"Clindamycin versus clindamycin plus rifampicin in hidradenitis suppurativa treatment: clinical and ultrasound observations","volume":"80","author":"Caro","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"2_suppl","key":"10.1016\/j.jaad.2024.09.015_bib6","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1177\/12034754221116115","article-title":"Practical guidelines for managing patients with hidradenitis suppurativa: an update","volume":"26","author":"Johnston","year":"2022","journal-title":"J Cutan Med Surg"},{"issue":"9","key":"10.1016\/j.jaad.2024.09.015_bib7","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1001\/archinte.162.9.985","article-title":"Rifampin and rifabutin drug interactions: an update","volume":"162","author":"Finch","year":"2002","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.jaad.2024.09.015_bib8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000321716","article-title":"Efficacy of rifampin-moxifloxacin-metronidazole combination therapy in hidradenitis suppurativa","volume":"222","author":"Join-Lambert","year":"2011","journal-title":"Dermatology"},{"issue":"2","key":"10.1016\/j.jaad.2024.09.015_bib9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2165\/11634300-000000000-00000","article-title":"Moxifloxacin safety: an analysis of 14 years of clinical data","volume":"12","author":"Tulkens","year":"2012","journal-title":"Drugs R D"},{"key":"10.1016\/j.jaad.2024.09.015_bib10","series-title":"StatPearls [internet]","first-page":"5","article-title":"Percutaneous central catheter","author":"Gonzalez","year":"2024"},{"issue":"1","key":"10.1016\/j.jaad.2024.09.015_bib11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/jamadermatol.2020.3385","article-title":"Investigation of suicidality and psychological adverse events in patients treated with finasteride","volume":"157","author":"Nguyen","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"7","key":"10.1016\/j.jaad.2024.09.015_bib12","first-page":"697","article-title":"The role of oral contraceptive pills in hidradenitis suppurativa: a cohort study","volume":"11","author":"Montero-Vilchez","year":"2021","journal-title":"Life (Basel)"},{"issue":"9","key":"10.1016\/j.jaad.2024.09.015_bib13","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1111\/j.1468-3083.2012.04668.x","article-title":"Metformin for the treatment of hidradenitis suppurativa: a little help along the way","volume":"27","author":"Verdolini","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.jaad.2024.09.015_bib14","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00403-020-02152-4","article-title":"Oral isotretinoin for the treatment of dermatologic conditions other than acne: a systematic review and discussion of future directions","volume":"313","author":"Chu","year":"2021","journal-title":"Arch Dermatol Res"},{"issue":"23","key":"10.1016\/j.jaad.2024.09.015_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232315250","article-title":"The role of hormones in hidradenitis suppurativa: a systematic review","volume":"23","author":"Abu Rached","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jaad.2024.09.015_bib16","article-title":"Spironolactone in hidradenitis suppurativa: a single-center","volume":"10","author":"Masson","year":"2024","journal-title":"Int J Womens Dermatol"},{"issue":"10","key":"10.1016\/j.jaad.2024.09.015_bib17","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1007\/s00105-020-04679-z","article-title":"[Endocrinological mechanisms in the pathophysiology of hidradenitis suppurativa]","volume":"71","author":"Nikolakis","year":"2020","journal-title":"Hautarzt"},{"issue":"6","key":"10.1016\/j.jaad.2024.09.015_bib18","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s40257-022-00725-9","article-title":"Drug survival of oral retinoids in hidradenitis suppurativa: a real-life cohort study","volume":"23","author":"Bouwman","year":"2022","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2024.09.015_bib19","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1365-2133.2010.10071.x","article-title":"Long-term results of acitretin therapy for hidradenitis suppurativa. Is acne inversa also a misnomer?","volume":"164","author":"Boer","year":"2011","journal-title":"Br J Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962224028639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962224028639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T21:10:59Z","timestamp":1733865059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962224028639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0190962224028639"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2024.09.015","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibiotic, hormonal\/metabolic, and retinoid therapies for hidradenitis suppurativa","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2024.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}